MediFind found 15 doctor with experience in Marginal Zone Lymphoma (MZL) near Burlington, VT. Of these, 13 are Experienced and 2 are Advanced.
University Of Vermont Medical Center Inc
Daniel Fram is a Radiation Oncologist in Burlington, Vermont. Dr. Fram is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Familial Prostate Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Prostate Cancer. Dr. Fram is currently accepting new patients.
University Of Vermont Medical Center Inc
Michael Latreille is a primary care provider, practicing in Internal Medicine in Burlington, Vermont. Dr. Latreille is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Crohn's Disease, Cirrhosis, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Endoscopy.
University Of Vermont Medical Center Inc
Harold Wallace is a Radiation Oncologist in Burlington, Vermont. Dr. Wallace is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Non-Muscle Invasive Bladder Cancer. Dr. Wallace is currently accepting new patients.
University Of Vermont Medical Center Inc
Eric Ganguly is a Gastroenterologist in Burlington, Vermont. Dr. Ganguly is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Barrett Esophagus, Choledocholithiasis, Pancreatic Cancer, Endoscopy, and Colonoscopy. Dr. Ganguly is currently accepting new patients.
University Of Vermont Medical Center Inc
Julian Sprague is a Hematologist and an Oncologist in Burlington, Vermont. Dr. Sprague is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Autoimmune Hemolytic Anemia, Large-Cell Immunoblastic Lymphoma, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Sprague is currently accepting new patients.
Champlain Valley Hematology Oncology PC
Paul Unger is a Hematologist Oncology specialist and a Hematologist in Colchester, Vermont. Dr. Unger is rated as an Advanced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Paget Disease of the Breast, Metastatic Insulinoma, Pancreatic Islet Cell Tumor, and Colorectal Cancer. Dr. Unger is currently accepting new patients.
University Of Vermont Medical Center Inc
Nicholas Ferrentino is a Gastroenterologist in Burlington, Vermont. Dr. Ferrentino is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Visceromegaly, Alcoholic Cirrhosis, Cirrhosis, Endoscopy, and Gastrectomy.
University Of Vermont Medical Center Inc
Nataniel Lester-Coll is a Radiation Oncologist and a Radiologist in Burlington, Vermont. Dr. Lester-Coll is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Familial Prostate Cancer, Lung Cancer, Small Cell Lung Cancer (SCLC), and Prostate Cancer. Dr. Lester-Coll is currently accepting new patients.
University Of Vermont Medical Center Inc
Sakshi Jasra is a Hematologist Oncology specialist and a Hematologist in Burlington, Vermont. Dr. Jasra is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Her top areas of expertise are Multiple Myeloma, Anemia, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jasra is currently accepting new patients.
University Of Vermont Medical Center Inc
John Miller is a primary care provider, practicing in Internal Medicine in Burlington, Vermont. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Sitosterolemia.
University Of Vermont Medical Center Inc
James Gerson is an Oncologist and a Hematologist in Burlington, Vermont. Dr. Gerson is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gerson is currently accepting new patients.
University Of Vermont Medical Center Inc
Eric Pillemer is a Hematologist Oncology specialist and an Oncologist in Burlington, Vermont. Dr. Pillemer is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Hairy Cell Leukemia (HCL), Neuroendocrine Tumor, and Paget Disease of the Breast.
University Of Vermont Medical Center Inc
Dustan Osborn is a Hematologist Oncology specialist and an Oncologist in Burlington, Vermont. Dr. Osborn is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Small Cell Lung Cancer (SCLC). Dr. Osborn is currently accepting new patients.
Champlain Valley Hematology Oncology PC
Dennis Sanders is an Oncologist in Colchester, Vermont. Dr. Sanders has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Neuroendocrine Tumor. Dr. Sanders is currently accepting new patients.
Joseph Haddock is a primary care provider, practicing in Family Medicine and Internal Medicine in Williston, Vermont. Dr. Haddock is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Marginal Zone Lymphoma (MZL), Shingles, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D).
Last Updated: 10/30/2025